- Home
- EXAS vs TLN Comparison
EXAS vs TLN Comparison
Compare EXAS & TLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXAS
- TLN
- Stock Information
- Founded
- EXAS 1995
- TLN 2015
- Country
- EXAS United States
- TLN United States
- Employees
- EXAS N/A
- TLN N/A
- Industry
- EXAS Medical Specialities
- TLN Electric Utilities: Central
- Sector
- EXAS Health Care
- TLN Utilities
- Exchange
- EXAS Nasdaq
- TLN Nasdaq
- Market Cap
- EXAS 8.8B
- TLN 8.1B
- IPO Year
- EXAS N/A
- TLN N/A
- Fundamental
- Price
- EXAS $43.06
- TLN $196.22
- Analyst Decision
- EXAS Strong Buy
- TLN Strong Buy
- Analyst Count
- EXAS 18
- TLN 11
- Target Price
- EXAS $70.59
- TLN $242.27
- AVG Volume (30 Days)
- EXAS 2.0M
- TLN 1.5M
- Earning Date
- EXAS 05-07-2025
- TLN 02-27-2025
- Dividend Yield
- EXAS N/A
- TLN N/A
- EPS Growth
- EXAS N/A
- TLN 681.86
- EPS
- EXAS N/A
- TLN 17.67
- Revenue
- EXAS $2,758,867,000.00
- TLN $2,073,000,000.00
- Revenue This Year
- EXAS $13.02
- TLN $9.02
- Revenue Next Year
- EXAS $13.02
- TLN $20.04
- P/E Ratio
- EXAS N/A
- TLN $11.18
- Revenue Growth
- EXAS 10.37
- TLN N/A
- 52 Week Low
- EXAS $40.62
- TLN $90.89
- 52 Week High
- EXAS $79.62
- TLN $258.03
- Technical
- Relative Strength Index (RSI)
- EXAS 36.15
- TLN 41.67
- Support Level
- EXAS $44.00
- TLN $198.18
- Resistance Level
- EXAS $47.23
- TLN $205.26
- Average True Range (ATR)
- EXAS 1.57
- TLN 9.81
- MACD
- EXAS 0.06
- TLN 0.18
- Stochastic Oscillator
- EXAS 15.86
- TLN 12.50
About EXAS Exact Sciences Corporation
Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening, too.
About TLN Talen Energy Corporation Common Stock
Talen Energy Corp is an independent power producer and energy infrastructure company. The company owns and operates approximately 10.7 gigawatts of power infrastructure in the United States. The group produces and sells electricity, capacity, and ancillary services into wholesale U.S. power markets, including PJM and WECC, with its generation fleet located in the Mid-Atlantic and Montana.